Sign in

CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company

ELUTIA INC.

Sign in to watch
Ticker
ELUT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474790334
Phone
240-247-1143
Business address
12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
Former names
AZIYO BIOLOGICS, INC.
  1. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 10,000 shares at an average $0.66 ($6,610)
  2. 4 Option exercise Director acquired 6,250 shares (option exercise)
  3. 4 Open-market buy PRESIDENT AND CEO bought 5,000 shares at $0.60 ($3,000)
  4. 4 Open-market buy Director bought 15,500 shares at $0.74 ($11,470)
  5. 4 Open-market buy PRESIDENT AND CEO bought 13,500 shares at an average $0.75 ($10,110)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 3,950 shares (to pay taxes)
  9. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 10,348 shares (to pay taxes)
  10. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 9,664 shares (to pay taxes)
  11. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 8,019 shares (to pay taxes)
  12. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,461 shares (to pay taxes)
  13. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 9,664 shares (to pay taxes)
  14. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 3,951 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Director bought 420,000 shares at $2.50 ($1,050,000)

Page 3 of 9 · 170 filings